Vamsee Yaganti, MD
Interventional Cardiology · Salt Lake City, UTNPI 1255591194
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (44.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Boston Scientific at 51.1% of the total. 2025 is the largest year on record at $125,239, 9.7 times the $12,965 reported in 2019. Among interventional cardiology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 916 payments — averaging $425.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$199K
- W. L. Gore & Associates, Inc.$125K
- Edwards Lifesciences$50K
- Abbott$7K
- Recor Medical Inc$4K
- Abiomed$2K
- plus $3K from 19 others
Across 92 payments — averaging $3642.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$298K
- W. L. Gore & Associates, Inc.$37K
What the payments were for
- Consulting fees$171,66544%
- Speaking & faculty fees$133,80034%
- Grants$13,5253%
- Travel & lodging$42,41011%
- Food & beverage$28,7547%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 541 | $199,381 |
| W. L. Gore & Associates, Inc. | 107 | $125,366 |
| Edwards Lifesciences | 78 | $49,533 |
| Abbott | 86 | $6,991 |
| Recor Medical Inc | 10 | $3,909 |
| Abiomed | 12 | $1,972 |
| Medtronic(2 entities) | 33 | $1,492 |
| Philips North America LLC | 15 | $786 |
| Teleflex LLC | 1 | $144 |
| E.r. Squibb & Sons, L.L.C. | 6 | $108 |
| Amgen | 5 | $83 |
| Pfizer | 5 | $83 |
| Novartis | 3 | $54 |
| Biotronik Inc. | 3 | $45 |
| Novo Nordisk | 1 | $33 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Impulse Dynamics (USA) Inc. | 1 | $24 |
| Chiesi USA, Inc. | 1 | $20 |
| Heartflow, Inc. | 1 | $20 |
| Bard Peripheral Vascular, Inc. | 1 | $16 |
| Lantheus Medical Imaging, Inc. | 1 | $15 |
| Circassia Inc. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $12 |
| Penumbra, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GORE CARDIOFORM Septal Occluder$107,514
- WATCHMAN Access System$71,020
- Watchman$54,180
- Edwards SAPIEN 3 Transcatheter Heart Valve$42,621
- GORE CARDIOFORM ASD Occluder$40,435
- WATCHMAN FLX$36,929
- CARDIOFORM Septal Occluder$12,822
- VersaCross Access Solution$10,508
- GENERAL - STRUCTURAL HEART$3,963
- Paradise Ultrasound Renal Denervation System$3,361
- SAPIEN 3 Ultra RESILIA$2,689
- MitraClip$1,904
- Product in Development$1,890
- Impella$1,791
- WATCHDOG$1,182
- Mitra Clip system$996
- NAVITOR$849
- EVOQUE$837
- GENERAL - THERAPIES$832
- (9525) Intracardiac Und$420
How this compares
$390,154 in reported general payments places this provider in the 95th percentile of 45 interventional cardiology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 232 | $257,303 |
| XareltoRivaroxaban | 68 | $88,657 |
| Repatha SureclickEvolocumab | 50 | $50,130 |
| EntrestoSacubitril/Valsartan | 20 | $36,777 |
| BrilintaTicagrelor | 44 | $28,070 |
| Repatha SyringeEvolocumab | 19 | $13,890 |
| FarxigaDapagliflozin Propanediol | 13 | $8,689 |
| Metoprolol Succinate | 391 | $5,633 |
| Atorvastatin Calcium | 612 | $5,160 |
| Potassium Chloride | 228 | $3,393 |
| Losartan Potassium | 375 | $3,325 |
| ClopidogrelClopidogrel Bisulfate | 361 | $3,179 |
| Carvedilol | 427 | $3,061 |
| Torsemide | 111 | $2,516 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 92 | $2,165 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $83 | $257,303232 claims |
| NovartisEntresto | $54 | $36,77720 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 45 interventional cardiology providers in Utah.
Other interventional cardiology in Salt Lake City
- Anwar TandarSalt Lake City$131K
- Stavros DrakosSalt Lake City$79K
- Frederick WeltSalt Lake City$26K
- Scott HackingSalt Lake City$22K
- Eric LindleySalt Lake City$18K
- Lee LinstrothSalt Lake City$14K
- Theophilus OwanSalt Lake City$9K
- Diana MeloSalt Lake City$4K
- Tara JonesSalt Lake City$4K
- Scott BrewsterSalt Lake City$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.